The fact AHZ could not reach anything like their projected market shows that trying to go it alone is extremely difficult . A company can have one of the best products in the world but trying to market one or two products by yourself world wide with limited capital is almost impossible . WP obviously had little choice , AHZ had the developed product but no way to get the exposure it needed to advance CardioCel and VascuCel so future ADAPT products including the TAVR would get recognition . Investors need to realise the type of salesmen needed to market these products are not going to be cheap as their Medical knowledge required would justify high wages . Really it would have been great if AHZ could have held both these products as ultimately they would have a range of ADAPT products which could justify a large sales team world wide Unfortunately it wasn’t to be but IMO WP has done a great job saving this company from almost certain bankruptcy . As I stated in previous posts IMO the vaccine section is what ultimately attracted investors but ultimately nearly lead to the company’s downfall . IMO AVR is on track to show investors the returns they assumed they would receive back in the early days of AHZ . Vaccines are always very risky and there was way to much hype generated by Frazers previous success . GLTATH
- Forums
- ASX - By Stock
- AVR
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-114
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M |
Open | High | Low | Value | Volume |
$18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $18.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.69 | 53 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 18.500 |
1 | 1000 | 18.400 |
1 | 20 | 18.230 |
1 | 1000 | 18.200 |
1 | 1000 | 18.000 |
Price($) | Vol. | No. |
---|---|---|
18.690 | 53 | 1 |
18.800 | 258 | 1 |
18.900 | 1029 | 2 |
18.910 | 100 | 1 |
19.500 | 21 | 1 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online